当前位置：
X-MOL 学术
›
World J. Stem Cells
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke.
World Journal of Stem Cells ( IF 3.6 ) Pub Date : 2017-9-21 , DOI: 10.4252/wjsc.v9.i8.133 Kam Sze Tsang 1 , Chi Ping Stephanie Ng 1 , Xian Lun Zhu 1 , George Kwok Chu Wong 1 , Gang Lu 1 , Anil Tejbhan Ahuja 2 , Ka Sing Lawrence Wong 3 , Ho Keung Ng 4 , Wai Sang Poon 1
World Journal of Stem Cells ( IF 3.6 ) Pub Date : 2017-9-21 , DOI: 10.4252/wjsc.v9.i8.133 Kam Sze Tsang 1 , Chi Ping Stephanie Ng 1 , Xian Lun Zhu 1 , George Kwok Chu Wong 1 , Gang Lu 1 , Anil Tejbhan Ahuja 2 , Ka Sing Lawrence Wong 3 , Ho Keung Ng 4 , Wai Sang Poon 1
Affiliation
To examine the safety and efficacy of mesenchymal stem cell (MSC) therapy for intracerebral haemorrhage with neurological dysfunctions for a year.
中文翻译：
自体骨髓源性间充质干细胞疗法治疗慢性卒中的I / II期随机对照试验。
若要检查间充质干细胞（MSC）治疗具有神经功能障碍的脑出血一年的安全性和有效性。
更新日期：2020-08-21
中文翻译：
自体骨髓源性间充质干细胞疗法治疗慢性卒中的I / II期随机对照试验。
若要检查间充质干细胞（MSC）治疗具有神经功能障碍的脑出血一年的安全性和有效性。
京公网安备 11010802027423号